Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 15, 2026 · Filed Apr 16, 2026
Gilead Sciences's Chief Comm & Corp Aff Officer sold $423K of Gilead Sciences shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$422,880
Shares × reported transaction price
64 days after results of Feb 10, 2026, 22 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $139.77 on Apr 15, 2026, 44% above its 52-week low and 10% below its high, after a 5% drop over the previous 30 trading days
52-week range $96.91 (May 9, 2025) to $155.80 (Feb 11, 2026), 73% of the way up, from 250 adjusted closes. 30 trading days earlier: $147.83 on Mar 3, 2026. Describes the past only, not a forecast
A WARN layoff notice covering 108 workers was filed in California on April 30, 2026.
From the official state WARN list, 15 days after the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -5.3% | +0.5% | -5.8% |
| 30 days | -5.8% | +4.0% | -9.8% |
| 90 days | -1.0% | +5.7% | -6.7% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.